DaVita (MEX:DVA) Other Financing: MXN-8,024 Mil (TTM As of Mar. 2026)


MEX:DVA DaVita Inc MEX:DVA
80 GF Score
Price MXN3,358.09
GF Value MXN2,218.74
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Other Financing?

DaVita MEX:DVA 80 Other Financing is MXN-8,024 Mil as of Mar. 2026. GuruFocus rates MEX:DVA with a GF Score™ of 80/100 and a GF Value™ of MXN2,218.74 (Significantly Overvalued). The stock has 6 warning signs investors should review.

DaVita's Other Financing for the three months ended in Mar. 2026 was MXN-2,942 Mil.

DaVita's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-8,024 Mil.

DaVita Other Financing Historical Data

* Premium members only.

The historical data trend for DaVita's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Other Financing Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,894.52 -6,359.56 -5,867.34 -11,690.77 -7,296.20

DaVita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,616.99 -1,365.04 -1,598.15 -2,118.93 -2,941.57
MEX:DVA
80GF Score
DaVita Inc MEX:DVA
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-8,024 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of MXN-8,024 Mil mean?
DaVita (MEX:DVA) has a Other Financing of MXN-8,024 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for DaVita and its competitors.
Is DaVita's Other Financing too high?
DaVita's current Other Financing is MXN-8,024 Mil. Overall, DaVita has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Other Financing compare to THC and EHC?
DaVita's Other Financing of MXN-8,024 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for DaVita and its competitors. DaVita's current Other Financing is MXN-8,024 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MEX:DVA) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN2,218.74, compared to a current price of MXN3,358.09 — trading 51.4% above its estimated fair value. The current Other Financing is MXN-8,024 Mil. DaVita's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For DaVita (MEX:DVA), the current Other Financing is MXN-8,024 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (MEX:DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of MXN3,358.09 is trading 51.4% above its estimated GF Value™ of MXN2,218.74. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for MEX:DVA:

  • Other Financing: MXN-8,024 Mil
  • GF Value™: MXN2,218.74 vs. price of MXN3,358.09 (51.4% above fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the MEX:DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
80GF Score

Get the complete analysis for MEX:DVA

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,358.09
Price
MXN2,218.74
GF Value